Review of current and potential applications of mesenchymal stem cells in exotic animal species.

This review explores how stem cell therapy might benefit exotic animals like reptiles, birds, and small mammals that have limited treatment options for common conditions. Researchers examined mesenchymal stem cells (MSCs), which are special cells from adult tissues that can reduce inflammation, fight infections, and help tissues heal. These cells have been successfully used in dogs and horses to treat arthritis, tendon injuries, and inflammatory diseases. The challenge with exotic pets is that many standard treatments don't work well for them—they process medications differently than cats and dogs, and therapies like physical therapy, laser treatment, massage, and acupuncture can be difficult or impossible to perform on small or uncooperative animals. While stem cell therapy has shown great promise in traditional veterinary medicine, its use in exotic species is still in early stages. The authors suggest MSCs could offer a new treatment option for conditions that are currently difficult to manage in these animals. The review highlights that more research is needed specifically in exotic species, but the existing evidence from other animals is encouraging. For exotic pet owners facing limited treatment choices, stem cell therapy may eventually provide hope for managing chronic conditions like arthritis that significantly impact quality of life. If you're considering any complementary therapies for your exotic pet, consult with a veterinarian who specializes in exotic animal medicine and has training in integrative approaches.

This narrative review examines the current state and future potential of mesenchymal stem cell (MSC) therapy in exotic animal species. The authors synthesize existing literature on MSC mechanisms, including anti-inflammatory, antimicrobial, and regenerative properties demonstrated in vitro and in vivo. While extensive veterinary clinical trials exist for domestic species treating osteoarthritis, soft tissue injuries, and infectious conditions, data specific to exotic species remains limited. The review identifies key challenges in exotic medicine: variable drug metabolism, medication tolerance issues, and practical limitations in delivering conventional therapies such as physical rehabilitation modalities and acupuncture. MSCs derived from mesenchymal tissues offer theoretical advantages for species where standard interventions are contraindicated or impractical. No specific sample sizes or effect sizes are provided as this is a review article rather than original research. Clinical takeaway: MSC therapy represents a promising but understudied therapeutic modality for exotic species, warranting further investigation given the limited treatment arsenal currently available for these patients.